CD71 in Dried Blood Spots in Healthy Males

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Healthy Athletes

In brief

Understand the effect of recombinant EPO (rEPO) boosting and microdosing on the hematological module of the Athlete Biological Passport (ABP) * Measure the change in CD71 longitudinally in subjects from both cohorts * Assess whether rEPO administration can be detected in a dried blood spot (DBS) using recent advances in analytical methodologies * Compare windows of rEPO detection using both Athlete Biological Passport models and direct detection using analytical methods in urine, blood, and DBS

Key facts

Study ID
NCT04073849
Run by
Sports Medicine Research and Testing Laboratory
People needed
24
Starts
2019-07-15
Expected to finish
2020-12-01
Last updated by the study team
2021-03-17

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.